Proteomic discovery of MNT as a novel interacting partner of E3 ubiquitin ligase E6AP and a key mediator of myeloid differentiation

Oncotarget

Volumn 7, Issue 7, 2016, Pages 7640-7656

  Kapoor, Isha ^a   Kanaujiya, Jitendra ^a   Kumar, Yogesh ^a   Thota, Jagadeshwar Reddy ^a   Bhatt, Madan L B ^b   Chattopadhyay, Naibedya ^a   Sanyal, Sabyasachi ^a   Trivedi, Arun Kumar ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

APL; ATRA; E6AP; Mass spectrometry; MNT

Indexed keywords

ALANINE; CYSTEINE; E6 ASSOCIATED PROTEIN; MAX PROTEIN; MNT PROTEIN; MYC PROTEIN; RETINOIC ACID; TRANSCRIPTION FACTOR; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; BIOLOGICAL MARKER; MNT PROTEIN, HUMAN; PROTEIN BINDING; REPRESSOR PROTEIN; UBE3A PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; G1 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; GENE SILENCING; HEK293T CELL; HL 60 CELL LINE; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEOMICS; UBIQUITIN MEDIATED PROTEASOME DEGRADATION; WILD TYPE; CELL CULTURE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; FLUORESCENT ANTIBODY TECHNIQUE; HEK293 CELL LINE; IMMUNOPRECIPITATION; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; METABOLISM; PATHOLOGY; PROCEDURES; PROMYELOCYTIC LEUKEMIA; WESTERN BLOTTING;

BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BIOMARKERS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HEK293 CELLS; HUMANS; IMMUNOPRECIPITATION; LEUKEMIA, PROMYELOCYTIC, ACUTE; MICROSCOPY, FLUORESCENCE; PROTEIN BINDING; PROTEOMICS; REPRESSOR PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; UBIQUITIN-PROTEIN LIGASES;

EID: 84958817208     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.6156     Document Type: Article

References (49)

1. Tenen DG. Disruption of differentiation in human cancer: AML shows the way. Nat Rev Cancer. 2003; 3:89-101.
2. Swords R, Freeman C and Giles F. Targeting the FMS-like tyrosine kinase 3 in acute myeloid leukemia. Leukemia. 26:2176-2185.
3. Rollig C, Bornhauser M, Thiede C, Taube F, Kramer M, Mohr B, Aulitzky W, Bodenstein H, Tischler HJ, Stuhlmann R, Schuler U, Stolzel F, von Bonin M, Wandt H, Schafer-Eckart K, Schaich M, et al. Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting system. J Clin Oncol. 29:2758-2765.
4. Stone RM, O'Donnell MR and Sekeres MA. Acute myeloid leukemia. Hematology Am Soc Hematol Educ Program. 2004:98-117.
5. Callens C, Coulon S, Naudin J, Radford-Weiss I, Boissel N, Raffoux E, Wang PH, Agarwal S, Tamouza H, Paubelle E, AsnafiV, Ribeil JA, Dessen P, Canioni D, Chandesris O, Rubio MT, et al. Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia. J Exp Med. 207:731-750.
6. Harris MN, Ozpolat B, Abdi F, Gu S, Legler A, Mawuenyega KG, Tirado-Gomez M, Lopez-Berestein G and Chen X. Comparative proteomic analysis of all-trans-retinoic acid treatment reveals systematic posttranscriptional control mechanisms in acute promyelocytic leukemia. Blood. 2004; 104:1314-1323.
7. Takeishi S, Matsumoto A, Onoyama I, Naka K, Hirao A and Nakayama KI. Ablation of Fbxw7 eliminates leukemia-initiating cells by preventing quiescence. Cancer Cell. 23:347-361.
8. Reavie L, Buckley SM, Loizou E, Takeishi S, Aranda-Orgilles B, Ndiaye-Lobry D, Abdel-Wahab O, Ibrahim S, Nakayama KI and Aifantis I. Regulation of c-Myc ubiquitination controls chronic myelogenous leukemia initiation and progression. Cancer Cell. 23:362-375.
9. Talis AL, Huibregtse JM and Howley PM. The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells. J Biol Chem. 1998; 273:6439-6445.
10. Mishra A, Godavarthi SK and Jana NR. UBE3A/E6-AP regulates cell proliferation by promoting proteasomal degradation of p27. Neurobiol Dis. 2009; 36:26-34.
11. Matentzoglu K and Scheffner M. Ubiquitin ligase E6-AP and its role in human disease. Biochem Soc Trans. 2008; 36:797-801.
12. Lochab S, Pal P, Kanaujiya JK, Tripathi SB, Kapoor I, Bhatt ML, Sanyal S, Behre G and Trivedi AK. Proteomic identification of E6AP as a molecular target of tamoxifen in MCF7 cells. Proteomics. 2012; 12:1363-1377.
13. Pal P, Lochab S, Kanaujiya JK, Kapoor I, Sanyal S, Behre G and Trivedi AK. E6AP, an E3 ubiquitin ligase negatively regulates granulopoiesis by targeting transcription factor C/EBPalpha for ubiquitin-mediated proteasome degradation. Cell Death Dis. 2013; 4:e590.
14. Fang Y, Zhou X, Lin M, Jing H, Zhong L, Ying M, Luo P, Yang B and He Q. The ubiquitin-proteasome pathway plays essential roles in ATRA-induced leukemia cells G0/G1 phase arrest and transition into granulocytic differentiation. Cancer Biol Ther. 10:1157-1167.
15. Sato T, Okumura F, Iguchi A, Ariga T and Hatakeyama S. TRIM32 promotes retinoic acid receptor alpha-mediated differentiation in human promyelogenous leukemic cell line HL60. Biochem Biophys Res Commun. 417:594-600.
16. Popov N, Wahlstrom T, Hurlin PJ and Henriksson M. Mnt transcriptional repressor is functionally regulated during cell cycle progression. Oncogene. 2005; 24:8326-8337.
17. Hurlin PJ, Zhou ZQ, Toyo-oka K, Ota S, Walker WL, Hirotsune S and Wynshaw-Boris A. Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis. EMBO J. 2003; 22:4584-4596.
18. Nilsson JA, Maclean KH, Keller UB, Pendeville H, Baudino TA and Cleveland JL. Mnt loss triggers Myc transcription targets, proliferation, apoptosis, and transformation. Mol Cell Biol. 2004; 24:1560-1569.
19. Guo XL, Pan L, Zhang XJ, Suo XH, Niu ZY, Zhang JY, Wang F, Dong ZR, Da W and Ohno R. Expression and mutation analysis of genes that encode the Myc antagonists Mad1, Mxi1 and Rox in acute leukaemia. Leuk Lymphoma. 2007; 48:1200-1207.
20. Louria-Hayon I, Alsheich-Bartok O, Levav-Cohen Y, Silberman I, Berger M, Grossman T, Matentzoglu K, Jiang YH, Muller S, Scheffner M, Haupt S and Haupt Y. E6AP promotes the degradation of the PML tumor suppressor. Cell Death Differ. 2009; 16:1156-1166.
21. Garcia A, Serrano A, Abril E, Jimenez P, Real LM, Canton J, Garrido F and Ruiz-Cabello F. Differential effect on U937 cell differentiation by targeting transcriptional factors implicated in tissue- or stage-specific induced integrin expression. Exp Hematol. 1999; 27:353-364.
22. Rots NY, Iavarone A, Bromleigh V and Freedman LP. Induced differentiation of U937 cells by 1,25-dihydroxyvitamin D3 involves cell cycle arrest in G1 that is preceded by a transient proliferative burst and an increase in cyclin expression. Blood. 1999; 93:2721-2729.
23. Lochab S, Pal P, Kapoor I, Kanaujiya JK, Sanyal S, Behre G and Trivedi AK. E3 ubiquitin ligase Fbw7 negatively regulates granulocytic differentiation by targeting G-CSFR for degradation. Biochim Biophys Acta. 2013; 1833:2639-2652.
24. Walker W, Zhou ZQ, Ota S, Wynshaw-Boris A and Hurlin PJ. Mnt-Max to Myc-Max complex switching regulates cell cycle entry. J Cell Biol. 2005; 169:405-413.
25. Borriello A, Cucciolla V, Criscuolo M, Indaco S, Oliva A, Giovane A, Bencivenga D, Iolascon A, Zappia V and Della Ragione F. Retinoic acid induces p27Kip1 nuclear accumulation by modulating its phosphorylation. Cancer Res. 2006; 66:4240-4248.
26. Nakagawa M, Oliva JL, Kothapalli D, Fournier A, Assoian RK and Kazanietz MG. Phorbol ester-induced G1 phase arrest selectively mediated by protein kinase Cdelta-dependent induction of p21. J Biol Chem. 2005; 280:33926-33934.
27. Shen M and Yen A. Nicotinamide cooperates with retinoic acid and 1,25-dihydroxyvitamin D(3) to regulate cell differentiation and cell cycle arrest of human myeloblastic leukemia cells. Oncology. 2009; 76:91-100.
28. Hurlin PJ, Queva C and Eisenman RN. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes Dev. 1997; 11:44-58.
29. Pal P, Kanaujiya JK, Lochab S, Tripathi SB, Bhatt ML, Singh PK, Sanyal S and Trivedi AK. 2-D gel electrophoresis-based proteomic analysis reveals that ormeloxifen induces G0-G1 growth arrest and ERK-mediated apoptosis in chronic myeloid leukemia cells K562. Proteomics. 2011; 11:1517-1529.
30. Dimberg A, Bahram F, Karlberg I, Larsson LG, Nilsson K and Oberg F. Retinoic acid-induced cell cycle arrest of human myeloid cell lines is associated with sequential down-regulation of c-Myc and cyclin E and posttranscriptional up-regulation of p27(Kip1). Blood. 2002; 99:2199-2206.
31. Wahlstrom T and Henriksson M. Mnt takes control as key regulator of the myc/max/mxd network. Adv Cancer Res. 2007; 97:61-80.
32. Ozeki M and Shively JE. Differential cell fates induced by all-trans retinoic acid-treated HL-60 human leukemia cells. J Leukoc Biol. 2008; 84:769-779.
33. Wu J, Zhu JQ, Han KK and Zhu DX. The role of the c-fms oncogene in the regulation of HL-60 cell differentiation. Oncogene. 1990; 5:873-877.
34. Baek YS, Haas S, Hackstein H, Bein G, Hernandez-Santana M, Lehrach H, Sauer S and Seitz H. Identification of novel transcriptional regulators involved in macrophage differentiation and activation in U937 cells. BMC Immunol. 2009; 10:18.
35. Nuber U, Schwarz SE and Scheffner M. The ubiquitin-protein ligase E6-associated protein (E6-AP) serves as its own substrate. Eur J Biochem. 1998; 254:643-649.
36. Schulein-Volk C, Wolf E, Zhu J, Xu W, Taranets L, Hellmann A, Janicke LA, Diefenbacher ME, Behrens A, Eilers M and Popov N. Dual regulation of Fbw7 function and oncogenic transformation by Usp28. Cell Rep. 2014; 9:1099-1109.
37. Smith AG, Popov N, Imreh M, Axelson H and Henriksson M. Expression and DNA-binding activity of MYCN/Max and Mnt/Max during induced differentiation of human neuroblastoma cells. J Cell Biochem. 2004; 92:1282-1295.
38. Bararia D, Trivedi AK, Zada AA, Greif PA, Mulaw MA, Christopeit M, Hiddemann W, Bohlander SK and Behre G. Proteomic identification of the MYST domain histone acetyltransferase TIP60 (HTATIP) as a co-activator of the myeloid transcription factor C/EBPalpha. Leukemia. 2008; 22:800-807.
39. Manz MG and Boettcher S. Emergency granulopoiesis. Nat Rev Immunol. 2014; 14:302-314.
40. Pabst T and Mueller BU. Transcriptional dysregulation during myeloid transformation in AML. Oncogene. 2007; 26:6829-6837.
41. Singh SM, Trivedi AK and Behre G. C/EBPalpha S248A mutation reduces granulocytic differentiation in human leukemic K562 cells. Biochem Biophys Res Commun. 2008; 369:692-694.
42. Trivedi AK, Bararia D, Christopeit M, Peerzada AA, Singh SM, Kieser A, Hiddemann W, Behre HM and Behre G. Proteomic identification of C/EBP-DBD multiprotein complex: JNK1 activates stem cell regulator C/EBPalpha by inhibiting its ubiquitination. Oncogene. 2007; 26:1789-1801.
43. Meroni G, Reymond A, Alcalay M, Borsani G, Tanigami A, Tonlorenzi R, Lo Nigro C, Messali S, Zollo M, Ledbetter DH, Brent R, Ballabio A and Carrozzo R. Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor. EMBO J. 1997; 16:2892-2906.
44. Shimoji T, Murakami K, Sugiyama Y, Matsuda M, Inubushi S, Nasu J, Shirakura M, Suzuki T, Wakita T, Kishino T, Hotta H, Miyamura T and Shoji I. Identification of annexin A1 as a novel substrate for E6AP-mediated ubiquitylation. J Cell Biochem. 2009; 106:1123-1135.
45. Nawaz Z, Lonard DM, Smith CL, Lev-Lehman E, Tsai SY, Tsai MJ and O'Malley BW. The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol Cell Biol. 1999; 19:1182-1189.
46. Kanaujiya JK, Lochab S, Kapoor I, Pal P, Datta D, Bhatt ML, Sanyal S, Behre G and Trivedi AK. Proteomic identification of Profilin1 as a corepressor of estrogen receptor alpha in MCF7 breast cancer cells. Proteomics. 2013; 13:2100-2112.
47. Katzerke C, Madan V, GerloffD, Brauer-Hartmann D, Hartmann JU, Wurm AA, Muller-Tidow C, Schnittger S, Tenen DG, Niederwieser D and Behre G. Transcription factor C/EBPalpha-induced microRNA-30c inactivates Notch1 during granulopoiesis and is downregulated in acute myeloid leukemia. Blood. 2013; 122:2433-2442.
48. Petrini M, Felicetti F, Bottero L, Errico MC, Morsilli O, Boe A, De Feo A and Care A. HOXB1 restored expression promotes apoptosis and differentiation in the HL60 leukemic cell line. Cancer Cell Int. 2013; 13:101.
49. Scholl C, Bansal D, Dohner K, Eiwen K, Huntly BJ, Lee BH, Rucker FG, Schlenk RF, Bullinger L, Dohner H, Gilliland DG and Frohling S. The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis. J Clin Invest. 2007; 117:1037-1048.